Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
ROC plot and AUC for CA125 and HE4 for patients with epithelial ovarian... | Download Scientific Diagram
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - ScienceDirect
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
HE4 & CA125 serum levels in patients with EOC according to tumor stage... | Download Table
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
![PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7968dca1873e681e0be5dd4a14690d730da0e0b2/4-Table1-1.png "PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar")
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar
Tumor marker (composed of CA125 and HE4) after surgery, during... | Download Scientific Diagram
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
CA125 and HE4 levels pre and post treatment for endometrial cancer | Download Table
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table
![PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ee64ab230d3264a10ced4c6827d39d8b87b0b704/3-Table2-1.png "PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar")